Idrocilamide

Idrocilamide
Clinical data
Trade names	Talval, Srilane, Relaxnova, Brolitène
AHFS/Drugs.com	International Drug Names
Routes of; administration	Topical
ATC code	M02AX05 (WHO) ;
Identifiers
	IUPAC name N-(2-hydroxyethyl)-3-phenyl-2-propenamide;
CAS Number	6961-46-2 ;
PubChem CID	1550874;
ChemSpider	1267352 ;
UNII	6C816LUB1O;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C11H13NO2
Molar mass	191.226 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C(\C=C\c1ccccc1)NCCO;
	InChI InChI=1S/C11H13NO2/c13-9-8-12-11(14)7-6-10-4-2-1-3-5-10/h1-7,13H,8-9H2,(H,12,14)/b7-6+ ; Key:OSCTXCOERRNGLW-VOTSOKGWSA-N ;
(what is this?) (verify)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Idrocilamide (trade names Talval, Srilane, Relaxnova, Brolitène^[1]^[2]) is a medication with skeletal muscle relaxant^[3] and anti-inflammatory actions^[4] used as a topical cream to treat lumbago and other kinds of muscular pain;^[5] it is available on prescription or over-the-counter^{[citation needed]} in France and various other countries.^[1]

Interactions

Idrocilamide has been reported to be a potent inhibitor of the metabolism of caffeine.^[6]^[7]

References

↑ ^1.0 ^1.1 Drugs.com: International Drug Names
↑ Drugfuture.com: Idrocilamide
↑ PMID 2085796 (PMID 2085796)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
↑ Bannwarth B, Le Huec JC, Vinçon G; et al. (December 1993). "[Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Rev Rhum Ed Fr (in French). 60 (12): 932–6. PMID 8012322.
↑ PMID 2140002 (PMID 2140002)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
↑ Carrillo JA, Benitez J (August 2000). "Clinically significant pharmacokinetic interactions between dietary caffeine and medications". Clin Pharmacokinet. 39 (2): 127–53. doi:10.2165/00003088-200039020-00004. PMID 10976659.
↑ Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC (January 1980). "Inhibition by idrocilamide of the disposition of caffeine". Eur. J. Clin. Pharmacol. 17 (1): 37–43. doi:10.1007/bf00561675. PMID 7371698.

Template:Topical products for joint and muscular pain

Template:Musculoskeletal-drug-stub

[Drugs.com-1] 1.0 ^1.1 Drugs.com: International Drug Names

[2] Drugfuture.com: Idrocilamide

[3] PMID 2085796 (PMID 2085796)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

[pmid8012322-4] Bannwarth B, Le Huec JC, Vinçon G; et al. (December 1993). "[Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Rev Rhum Ed Fr (in French). 60 (12): 932–6. PMID 8012322.

[5] PMID 2140002 (PMID 2140002)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

[pmid10976659-6] Carrillo JA, Benitez J (August 2000). "Clinically significant pharmacokinetic interactions between dietary caffeine and medications". Clin Pharmacokinet. 39 (2): 127–53. doi:10.2165/00003088-200039020-00004. PMID 10976659.

[pmid7371698-7] Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC (January 1980). "Inhibition by idrocilamide of the disposition of caffeine". Eur. J. Clin. Pharmacol. 17 (1): 37–43. doi:10.1007/bf00561675. PMID 7371698.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Idrocilamide

Interactions

References

Navigation menu